Buy Divi's Laboratories, target price Rs 3480: Reliance Securities

Reliance Securities has buy call on Divi's Laboratories with a target price of Rs 3480. The current market price of Divi's Laboratories is Rs 3358. Time period given by analyst is Intra Day when Divi's Laboratories price can reach defined target. Reliance Securities recommended to keep stop loss at Rs 3330.

Divi's Laboratories, incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 90499.57 Crore) operating in Pharmaceuticals sector.

Financials

For the quarter ended 30-09-2022, the company has reported a Consolidated Total Income of Rs 1934.62 Crore, down -17.43 % from last quarter Total Income of Rs 2342.91 Crore and down -3.59 % from last year same quarter Total Income of Rs 2006.62 Crore. Company has reported net profit after tax of Rs 493.60 Crore in latest quarter.

The company’s top management includes Dr.Ramesh B V Nimmagadda, Dr.S Ganapaty, Prof.Sunaina Singh, Mr.R Ranga Rao, Dr.G Suresh Kumar, Mr.K V K Seshavataram, Mr.N V Ramana, Mr.Madhusudana Rao Divi, Ms.Nilima Prasad Divi, Dr.Kiran S Divi, Dr.Murali K Divi, Mr.K V Chowdary. Company has Price Waterhouse Chartered Accountants LLP as its auditors. As on 30-09-2022, the company has a total of 27 Crore shares outstanding.

Promoter/FII Holdings
Promoters held 51.94 per cent stake in the company as of 30-Sep-2022, while FIIs owned 22.1 per cent, DIIs 20.64 per cent.